Short Summary
VirtaMove successfully defended the Director's discretionary denial of institution for Google’s IPR, arguing statutory authority and rejecting judicial estoppel. The rehearing request was denied, leaving the IPR uninstated.
Detailed Summary
In response to Google’s petition for rehearing of the Director’s discretionary denial of institution, VirtaMove contended that the Director acted within the authority granted by 35 U.S.C. §§ 314 and 316, appropriately weighing patent age among other policy factors. The patent owner further argued that judicial estoppel does not bind the Patent Office and that the Director’s decision is final and non‑appealable. The PTAB denied the rehearing request, upholding the denial of institution and effectively terminating the IPR proceeding.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Google LLC vs VirtaMove, Corp. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Webgroup Czech Republic, a.s. et al.vsDISH Technologies L.L.C. et al.
WebGroup Czech Republic petitions the PTAB to invalidate DISH's adaptive‑bitrate streaming patent, asserting obviousness over four prior‑art references. The Board is asked to institute the IPR.
Intel CorporationvsAdvanced Cluster Systems, Inc.
Intel seeks rehearing after the PTAB Director denied institution of IPR2025‑00794, arguing that a recent $8.9 billion U.S. government investment makes its Xeon chips a national‑security priority and that the denial misapprehended this.
Aylo Freesites Ltd et al.vsDISH Technologies L.L.C. et al.
Aylo Freesites requests Director Review after the PTAB denied institution of its IPR on DISH's multi‑bitrate streaming patent, arguing the Board misapplied General Plastic factors and ignored the merits of the Leaning reference.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
The PTAB held that all 34 claims of Netlist's ’060 memory‑package patent are obvious over prior art such as Kim, Rajan, Riho, and Wyman. Samsung and its Micron co‑petitioners prevailed, leading to a complete invalidation of the patent.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB held that Imperative Care proved all nine claims of Inari Medical’s 11,697,011 B2 hemostasis valve patent are unpatentable, finding the term “filament” must be flexible and that the prior art renders the claims obvious.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.